№ files_lp_4_process_2_82669
File format: docx Character count: 2641 File size: 57 KB
Register of declared financial and professional interests of committee members and experts involved in the appraisal of Talazoparib with enzalutamide for metastatic prostate cancer, specifying potential conflicts and participation permissions.
Year: 2025
Organization: NICE Technology Appraisal Committee
Document type: Interests Register
Region: United Kingdom
Subject: Conflicts of interest in health technology appraisal
Participants: Peter Wheatley Price, Warren Linley, David McAllister, Professor Suneil Jain, Rhiannon Owen, Holly Knight
Date of publication: TBC
Relevant period: 2025
Financial interests: Pfizer, AstraZeneca, Bayer, Astellas, Johnson & Johnson, Boston Scientific, Teleflex, Accord, Molli Surgical, BXT Nanotherapy
Professional roles: Committee members, clinical expert, patient expert
Access to trial data: Yes
Appraisal ID: 4004
Record type: Committee disclosures
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Topics: hormone-relapsed ID4004 Talazoparib